Related Experiment Video
Updated: May 9, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
National Eye Institute Visual Function Questionnaire: usefulness in glaucoma.
Nariman Nassiri1, Shiva Mehravaran, Kouros Nouri-Mahdavi
1Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, USA.
The National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ-25) is a key tool for assessing glaucoma patients' quality of life. Adding items on contrast sensitivity, glare, and dark adaptation may improve its responsiveness to vision changes.
Area of Science:
- Ophthalmology
- Patient-Reported Outcomes
Background:
- The National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ-25) is widely used to evaluate vision-related quality of life in glaucoma patients.
- Glaucoma significantly impacts NEI-VFQ-25 scores, with effects correlating to visual field loss severity.
Purpose of the Study:
- To assess the impact of glaucoma on the NEI-VFQ-25.
- To identify potential improvements for the NEI-VFQ-25 to enhance its responsiveness in glaucoma patients.
Main Methods:
- Analysis of NEI-VFQ-25 composite and subscale scores in glaucoma patients.
- Correlation of NEI-VFQ-25 scores with glaucomatous visual field loss severity.
Main Results:
- Glaucoma negatively affects overall and specific NEI-VFQ-25 scores.
- The degree of negative impact is linked to the severity of visual field loss.
Conclusions:
- The NEI-VFQ-25 is sensitive to the effects of glaucoma on quality of life.
- Incorporating contrast sensitivity, glare, and dark adaptation items could improve the NEI-VFQ-25's utility for glaucoma patients.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
